Ajanta Pharma Limited — Dividend/Bonus, 28-10-2024: Dividend

Ajanta Pharma reported a strong Q2 FY 2025, achieving a 15% increase in revenue to ₹1,187 crore. The Board approved a first interim dividend of ₹28 per share, totaling ₹350 crore. Key highlights include a 12% rise in EBITDA and a 15% increase in profit after tax, reaching ₹216 crore. The company maintained healthy cash flows, with robust performance across its branded generic businesses in India, Asia, and Africa.